상품명칭 |
Lixazinone |
별명 |
Lixazinone [INN]; Lixazinona; Lixazinona [Spanish]; Lixazinonum; Lixazinonum [Latin]; N-Cyclohexyl-N-methyl-4-(2-oxo-1,2,3,5-tetrahydroimidazo(2,1-b)quinazolin-7-yl)oxybutyramide; Butanamide, N-cyclohexyl-N-methyl-4-((1,2,3,5-tetrahydro-2-oxoimidazo(2,1-b)quinazolin-7-yl)oxy)-; Butanamide, N-cyclohexyl-N-methyl-4-((2-oxo-1,2,3,5-tetrahydroimidazo(2,1-b)quinazolin-7-yl)oxy)-; N-cyclohexyl-N-methyl-4-[(2-oxo-2,3,5,10-tetrahydroimidazo[2,1-b]quinazolin-7-yl)oxy]butanamide |
분자식 |
C21H28N4O3 |
분자량 |
384.472 |
InChI |
InChI=1/C21H28N4O3/c1-24(16-6-3-2-4-7-16)20(27)8-5-11-28-17-9-10-18-15(12-17)13-25-14-19(26)23-21(25)22-18/h9-10,12,16H,2-8,11,13-14H2,1H3,(H,22,23,26) |
cas번호 |
94192-59-3 |
분자 구조 |
|
밀도 |
1.33g/cm3 |
비등점 |
579.2°C at 760 mmHg |
굴절 지수 |
1.659 |
인화점 |
304.1°C |
위험성 표시 |
|
리스크 규칙 |
|
보안 규칙 |
|
|